nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0474	0.0474	CbGpPWpGaD
Carbachol—CHRM1—Monoamine GPCRs—DRD4—conduct disorder	0.0383	0.0383	CbGpPWpGaD
Carbachol—CHRM3—Monoamine GPCRs—DRD4—conduct disorder	0.0382	0.0382	CbGpPWpGaD
Carbachol—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.0378	0.0378	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0356	0.0356	CbGpPWpGaD
Carbachol—CHRM1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0322	0.0322	CbGpPWpGaD
Carbachol—CHRM3—Amine ligand-binding receptors—DRD4—conduct disorder	0.0321	0.0321	CbGpPWpGaD
Carbachol—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0318	0.0318	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—GABRA2—conduct disorder	0.0273	0.0273	CbGpPWpGaD
Carbachol—CHRM1—Monoamine GPCRs—HTR2A—conduct disorder	0.025	0.025	CbGpPWpGaD
Carbachol—CHRM3—Monoamine GPCRs—HTR2A—conduct disorder	0.0249	0.0249	CbGpPWpGaD
Carbachol—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.0247	0.0247	CbGpPWpGaD
Carbachol—CHRM1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.021	0.021	CbGpPWpGaD
Carbachol—CHRM3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0209	0.0209	CbGpPWpGaD
Carbachol—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0207	0.0207	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.0171	0.0171	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.017	0.017	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Other—DRD4—conduct disorder	0.0169	0.0169	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.0168	0.0168	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0164	0.0164	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0163	0.0163	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0162	0.0162	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—COMT—conduct disorder	0.0131	0.0131	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—MAOA—conduct disorder	0.013	0.013	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0117	0.0117	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0116	0.0116	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0113	0.0113	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0113	0.0113	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0112	0.0112	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Other—HTR2A—conduct disorder	0.0111	0.0111	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.011	0.011	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—SLC6A4—conduct disorder	0.00959	0.00959	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.00902	0.00902	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00873	0.00873	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.00861	0.00861	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CGA—conduct disorder	0.00858	0.00858	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.00849	0.00849	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.00786	0.00786	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00739	0.00739	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00736	0.00736	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CGA—conduct disorder	0.00735	0.00735	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00729	0.00729	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00711	0.00711	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00633	0.00633	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00631	0.00631	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00625	0.00625	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00623	0.00623	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—HTR2A—conduct disorder	0.00621	0.00621	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00558	0.00558	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00556	0.00556	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.0054	0.0054	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CGA—conduct disorder	0.00519	0.00519	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.00486	0.00486	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CGA—conduct disorder	0.00485	0.00485	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00482	0.00482	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.00482	0.00482	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0048	0.0048	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—DRD4—conduct disorder	0.0048	0.0048	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.0048	0.0048	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00476	0.00476	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.00476	0.00476	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.00442	0.00442	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CGA—conduct disorder	0.0044	0.0044	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00436	0.00436	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CGA—conduct disorder	0.00434	0.00434	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00413	0.00413	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00412	0.00412	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—DRD4—conduct disorder	0.00411	0.00411	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00408	0.00408	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00377	0.00377	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—WASF1—conduct disorder	0.00348	0.00348	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	0.00314	0.00314	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	0.00313	0.00313	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—EP300—conduct disorder	0.00312	0.00312	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CGA—conduct disorder	0.00311	0.00311	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.0031	0.0031	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	0.00272	0.00272	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.00269	0.00269	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HTR2A—conduct disorder	0.00268	0.00268	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CGA—conduct disorder	0.00261	0.00261	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CGA—conduct disorder	0.0026	0.0026	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CGA—conduct disorder	0.00258	0.00258	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—EP300—conduct disorder	0.00248	0.00248	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—DRD4—conduct disorder	0.00247	0.00247	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—DRD4—conduct disorder	0.00247	0.00247	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.00244	0.00244	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DRD4—conduct disorder	0.00243	0.00243	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—COMT—conduct disorder	0.00234	0.00234	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—MAOA—conduct disorder	0.00233	0.00233	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00226	0.00226	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—WASF1—conduct disorder	0.00209	0.00209	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—WASF1—conduct disorder	0.00208	0.00208	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.00206	0.00206	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	0.00178	0.00178	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	0.00177	0.00177	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.00175	0.00175	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.00159	0.00159	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HTR2A—conduct disorder	0.00159	0.00159	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DRD4—conduct disorder	0.00146	0.00146	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DRD4—conduct disorder	0.00146	0.00146	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—COMT—conduct disorder	0.0014	0.0014	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—MAOA—conduct disorder	0.00139	0.00139	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—EP300—conduct disorder	0.001	0.001	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HTR2A—conduct disorder	0.000953	0.000953	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HTR2A—conduct disorder	0.00095	0.00095	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.000941	0.000941	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EP300—conduct disorder	0.00084	0.00084	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—EP300—conduct disorder	0.000602	0.000602	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EP300—conduct disorder	0.000505	0.000505	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EP300—conduct disorder	0.000503	0.000503	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EP300—conduct disorder	0.000498	0.000498	CbGpPWpGaD
